David James Lennon

Chief Executive Officer at Whitehawk Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Whitehawk Therapeutics Inc., 3 years.

Whitehawk Therapeutics Inc. Director · CHIEF EXECUTIVE OFFICER
3 years · Since 2023

Chief executive roles

Whitehawk Therapeutics Inc. · Chief Executive Officer
Since October 2023
0 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
0

-22.3% a year in revenue

20% of the scoring weight is on file. Figures cover December 2022 – December 2025.

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 14, 2026 Whitehawk Therapeutics Inc. Grant or award +51,021 $3.92 $200,002
Apr 9, 2026 Whitehawk Therapeutics Inc. Open-market sale −14,500 $3.38 $49,010
Apr 8, 2026 Whitehawk Therapeutics Inc. Open-market sale −63,945 $3.40 $217,413
Apr 7, 2026 Whitehawk Therapeutics Inc. Open-market sale −94,087 $3.43 $322,718
Apr 6, 2026 Whitehawk Therapeutics Inc. Open-market sale −102,395 $3.51 $359,406
Apr 2, 2026 Whitehawk Therapeutics Inc. Open-market sale −26,858 $3.48 $93,466
Apr 1, 2026 Whitehawk Therapeutics Inc. Option exercise +775,828 — —
Mar 2, 2026 Whitehawk Therapeutics Inc. Open-market sale −5,100 $3.31 $16,881
Mar 1, 2026 Whitehawk Therapeutics Inc. Option exercise +16,250 — —
Mar 3, 2025 Whitehawk Therapeutics Inc. Open-market sale −5,690 $2.35 $13,372
Mar 1, 2025 Whitehawk Therapeutics Inc. Option exercise +16,250 — —
Oct 3, 2024 Whitehawk Therapeutics Inc. Open-market sale −9,689 $1.94 $18,797
Oct 2, 2024 Whitehawk Therapeutics Inc. Option exercise +32,558 — —

Questions about David James Lennon

What boards is David James Lennon on?

David James Lennon sits on the board of Whitehawk Therapeutics Inc.

What company is David James Lennon the CEO of?

David James Lennon has been Chief Executive Officer of Whitehawk Therapeutics Inc. since October 2023.

How long has David James Lennon served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.